In new case study, CyPath Lung spares elderly woman from an invasive procedure for a suspicious lung nodule discovered on a ...
WTKR News 3 Norfolk, VA on MSN
Robotic technology helps doctors reach previously inaccessible lung nodules
None ...
Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and ...
News-Medical.Net on MSN
CNN-based system improves lung nodule detection and classification
Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.
The proposed CNN-based system demonstrates the feasibility and robustness of deep learning for automatic lung nodule detection and classification. Despite strong results, the study acknowledges ...
WBAL TV Baltimore on MSN
Lung cancer cases triple among non-smokers
Lung cancer is one of the most common cancers for men and women and by far the deadliest — it kills more people than colon, breast and prostate cancers combined. Lung cancer rates overall have been ...
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby, and I will be your conference ...
7don MSN
Can tuberculosis treatment be safely shortened? New studies look inside the lungs for answers
Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...
Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...
The FDA has cleared RevealDx’s AI-powered lung nodule risk assessment software, RevealAI-Lung, according to a company press ...
Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.
The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results